312 related articles for article (PubMed ID: 26583267)
1. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
3. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.
Wong RJ; Devaki P; Nguyen L; Cheung R; Nguyen MH
Liver Transpl; 2014 May; 20(5):528-35. PubMed ID: 24415542
[TBL] [Abstract][Full Text] [Related]
4. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
5. Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
Ahn J; Liu B; Bhuket T; Wong RJ
Dig Dis Sci; 2017 Apr; 62(4):1051-1057. PubMed ID: 28168576
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
[TBL] [Abstract][Full Text] [Related]
7. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
8. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.
Davila JA; El-Serag HB
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):104-10; quiz 4-5. PubMed ID: 16431312
[TBL] [Abstract][Full Text] [Related]
11. Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival.
Yan M; Ha J; Aguilar M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2017 Apr; 51(4):378-383. PubMed ID: 27380460
[TBL] [Abstract][Full Text] [Related]
12. Increased long-term survival among patients with hepatocellular carcinoma after implementation of Model for End-stage Liver Disease score.
Wong RJ; Devaki P; Nguyen L; Cheung R; Cho-Phan C; Nguyen MH
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1534-40.e1. PubMed ID: 24361414
[TBL] [Abstract][Full Text] [Related]
13. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
Wong RJ; Ahmed A
Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
[TBL] [Abstract][Full Text] [Related]
14. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
15. Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era.
Devaki P; Wong RJ; Marupakula V; Nangia S; Nguyen L; Ditah IC; Ehrinpreis MN; Nguyen MH
Cancer; 2014 Jun; 120(11):1725-32. PubMed ID: 24590359
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
[TBL] [Abstract][Full Text] [Related]
17. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
18. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
19. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]